Where this storyline stands
Adding oral antihistamines to existing eczema treatments is unlikely to lead to clinically important reductions in eczema and itch severity and may not reduce sleep disturbance or flare-ups, finds a review of the latest trial evidence published by The BMJ today.
Complete chronological journey
Every chapter below is ordered by its exact event time, from the earliest connected report to the newest development.
- 01How it started01 — How it started
Antihistamines likely offer no meaningful benefit for eczema and may increase harms
What happened
Adding oral antihistamines to existing eczema treatments is unlikely to lead to clinically important reductions in eczema and itch severity and may not reduce sleep disturbance or flare-ups, finds a review of the latest trial evidence published by The BMJ toda Antihistamines likely offer no meaningful benefit for eczema and may increase harms
Why it matters
The development may affect how technology is built, regulated or used. The practical impact depends on technical details, availability and independent evaluation.